Copyright
©The Author(s) 2025.
World J Transplant. Sep 18, 2025; 15(3): 101518
Published online Sep 18, 2025. doi: 10.5500/wjt.v15.i3.101518
Published online Sep 18, 2025. doi: 10.5500/wjt.v15.i3.101518
Table 2 Summary of demographic characteristics of study sample by group (n = 52), n (%)
| Pre-protocol group (n = 26) | Post-protocol group (n = 26) | |
| Gender | ||
| Female | 21 (80.8) | 18 (69.2) |
| Male | 5 (19.2) | 8 (30.8) |
| Age (years) | ||
| Median [IQR] | 47.0 (33.0, 58.0) | 49.0 (40.0, 58.0) |
| ≤ 45 | 12 (46.2) | 11 (42.3) |
| Admission weight (kg) | ||
| Median [IQR] | 76.8 (64.1, 87.0) | 76.8 (68.0, 96.2) |
| Ethnicity | ||
| African-American | 7 (26.9) | 5 (19.2) |
| Caucasian | 14 (53.8) | 14 (53.8) |
| Hispanic | 5 (19.2) | 1 (3.8) |
| Unknown | 0 (0.0) | 6 (23.1) |
- Citation: Ly K, Di Carlo A, Karhadkar SS, Chavin K, Graziano F, Maberry K, Sifontis N, Yu D, Lu X, Diamond A. Implementation of an opioid-sparing protocol utilizing liposomal bupivacaine and intravenous ketorolac for pain management after living kidney donation. World J Transplant 2025; 15(3): 101518
- URL: https://www.wjgnet.com/2220-3230/full/v15/i3/101518.htm
- DOI: https://dx.doi.org/10.5500/wjt.v15.i3.101518